Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Submitted by
admin
on November 8, 2013 - 9:13am
Source:
Yahoo/
News Tags:
IMMU-132
Immunomedics
solid tumors
Headline:
Immunomedics announces IMMU-132 is active in patients refractory to Irinotecan
Do Not Allow Advertisers to Use My Personal information
